Global Basal Insulin (Long-Acting Insulin) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Basal Insulin (Long-Acting Insulin) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Basal Insulin (Long-Acting Insulin) by Country/Region, 2017, 2022 & 2028

2.2 Basal Insulin (Long-Acting Insulin) Segment by Type

2.2.1 Lantus

2.2.2 Levemir

2.2.3 Tresiba

2.2.4 Toujeo

2.2.5 Basaglar

2.2.6 Biosimilar Glargines

2.3 Basal Insulin (Long-Acting Insulin) Sales by Type

2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2017-2022)

2.4 Basal Insulin (Long-Acting Insulin) Segment by Application

2.4.1 Type 1 Diabetes

2.4.2 Type 2 Diabetes

2.5 Basal Insulin (Long-Acting Insulin) Sales by Application

2.5.1 Global Basal Insulin (Long-Acting Insulin) Sale Market Share by Application (2017-2022)

2.5.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2017-2022)

3 Global Basal Insulin (Long-Acting Insulin) by Company

3.1 Global Basal Insulin (Long-Acting Insulin) Breakdown Data by Company

3.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Company (2020-2022)

3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2020-2022)

3.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Company (2020-2022)

3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2020-2022)

3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2020-2022)

3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Company

3.4 Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Location Distribution

3.4.2 Players Basal Insulin (Long-Acting Insulin) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Basal Insulin (Long-Acting Insulin) by Geographic Region

4.1 World Historic Basal Insulin (Long-Acting Insulin) Market Size by Geographic Region (2017-2022)

4.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Geographic Region

4.2 World Historic Basal Insulin (Long-Acting Insulin) Market Size by Country/Region (2017-2022)

4.2.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Country/Region

4.3 Americas Basal Insulin (Long-Acting Insulin) Sales Growth

4.4 APAC Basal Insulin (Long-Acting Insulin) Sales Growth

4.5 Europe Basal Insulin (Long-Acting Insulin) Sales Growth

4.6 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Growth

5 Americas

5.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country

5.1.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022)

5.1.2 Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022)

5.2 Americas Basal Insulin (Long-Acting Insulin) Sales by Type

5.3 Americas Basal Insulin (Long-Acting Insulin) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region

6.1.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022)

6.1.2 APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022)

6.2 APAC Basal Insulin (Long-Acting Insulin) Sales by Type

6.3 APAC Basal Insulin (Long-Acting Insulin) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Basal Insulin (Long-Acting Insulin) by Country

7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022)

7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022)

7.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Type

7.3 Europe Basal Insulin (Long-Acting Insulin) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) by Country

8.1.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022)

8.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type

8.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin)

10.3 Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)

10.4 Industry Chain Structure of Basal Insulin (Long-Acting Insulin)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Basal Insulin (Long-Acting Insulin) Distributors

11.3 Basal Insulin (Long-Acting Insulin) Customer

12 World Forecast Review for Basal Insulin (Long-Acting Insulin) by Geographic Region

12.1 Global Basal Insulin (Long-Acting Insulin) Market Size Forecast by Region

12.1.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Region (2023-2028)

12.1.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Basal Insulin (Long-Acting Insulin) Forecast by Type

12.7 Global Basal Insulin (Long-Acting Insulin) Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered

13.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Sanofi Aventis

13.2.1 Sanofi Aventis Company Information

13.2.2 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered

13.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Aventis Main Business Overview

13.2.5 Sanofi Aventis Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered

13.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Biocon

13.4.1 Biocon Company Information

13.4.2 Biocon Basal Insulin (Long-Acting Insulin) Product Offered

13.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biocon Main Business Overview

13.4.5 Biocon Latest Developments

13.5 Julphar

13.5.1 Julphar Company Information

13.5.2 Julphar Basal Insulin (Long-Acting Insulin) Product Offered

13.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Julphar Main Business Overview

13.5.5 Julphar Latest Developments

13.6 Exir

13.6.1 Exir Company Information

13.6.2 Exir Basal Insulin (Long-Acting Insulin) Product Offered

13.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Exir Main Business Overview

13.6.5 Exir Latest Developments

13.7 Sedico

13.7.1 Sedico Company Information

13.7.2 Sedico Basal Insulin (Long-Acting Insulin) Product Offered

13.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sedico Main Business Overview

13.7.5 Sedico Latest Developments

13.8 Wockhardt

13.8.1 Wockhardt Company Information

13.8.2 Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered

13.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Wockhardt Main Business Overview

13.8.5 Wockhardt Latest Developments

14 Research Findings and Conclusion

Table 1. Basal Insulin (Long-Acting Insulin) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Basal Insulin (Long-Acting Insulin) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lantus

Table 4. Major Players of Levemir

Table 5. Major Players of Tresiba

Table 6. Major Players of Toujeo

Table 7. Major Players of Basaglar

Table 8. Major Players of Biosimilar Glargines

Table 9. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 10. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

Table 11. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & ($ million)

Table 12. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2022)

Table 13. Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2017-2022) & (US$/Unit)

Table 14. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022)

Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2022)

Table 18. Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2017-2022) & (US$/Unit)

Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Company (2020-2022) & (K Units)

Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2020-2022)

Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2020-2022)

Table 23. Global Basal Insulin (Long-Acting Insulin) Sale Price by Company (2020-2022) & (US$/Unit)

Table 24. Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution and Sales Area

Table 25. Players Basal Insulin (Long-Acting Insulin) Products Offered

Table 26. Basal Insulin (Long-Acting Insulin) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Basal Insulin (Long-Acting Insulin) Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Geographic Region (2017-2022)

Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Basal Insulin (Long-Acting Insulin) Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Country/Region (2017-2022)

Table 35. Global Basal Insulin (Long-Acting Insulin) Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 38. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2022)

Table 39. Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2022)

Table 41. Americas Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 42. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

Table 43. Americas Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 44. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Table 45. APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)

Table 46. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)

Table 47. APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2022)

Table 49. APAC Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 50. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

Table 51. APAC Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 52. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Table 53. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 54. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2022)

Table 55. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2022)

Table 57. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 58. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

Table 59. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 60. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Basal Insulin (Long-Acting Insulin)

Table 70. Key Market Challenges & Risks of Basal Insulin (Long-Acting Insulin)

Table 71. Key Industry Trends of Basal Insulin (Long-Acting Insulin)

Table 72. Basal Insulin (Long-Acting Insulin) Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Basal Insulin (Long-Acting Insulin) Distributors List

Table 75. Basal Insulin (Long-Acting Insulin) Customer List

Table 76. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Basal Insulin (Long-Acting Insulin) Sales Market Forecast by Region

Table 78. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Application (2023-2028)

Table 96. Novo Nordisk Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 97. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered

Table 98. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 99. Novo Nordisk Main Business

Table 100. Novo Nordisk Latest Developments

Table 101. Sanofi Aventis Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 102. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered

Table 103. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 104. Sanofi Aventis Main Business

Table 105. Sanofi Aventis Latest Developments

Table 106. Eli Lilly Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 107. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered

Table 108. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 109. Eli Lilly Main Business

Table 110. Eli Lilly Latest Developments

Table 111. Biocon Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 112. Biocon Basal Insulin (Long-Acting Insulin) Product Offered

Table 113. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 114. Biocon Main Business

Table 115. Biocon Latest Developments

Table 116. Julphar Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 117. Julphar Basal Insulin (Long-Acting Insulin) Product Offered

Table 118. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 119. Julphar Main Business

Table 120. Julphar Latest Developments

Table 121. Exir Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 122. Exir Basal Insulin (Long-Acting Insulin) Product Offered

Table 123. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 124. Exir Main Business

Table 125. Exir Latest Developments

Table 126. Sedico Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 127. Sedico Basal Insulin (Long-Acting Insulin) Product Offered

Table 128. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 129. Sedico Main Business

Table 130. Sedico Latest Developments

Table 131. Wockhardt Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors

Table 132. Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered

Table 133. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 134. Wockhardt Main Business

Table 135. Wockhardt Latest Developments

List of Figures

Figure 1. Picture of Basal Insulin (Long-Acting Insulin)

Figure 2. Basal Insulin (Long-Acting Insulin) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Basal Insulin (Long-Acting Insulin) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lantus

Figure 10. Product Picture of Levemir

Figure 11. Product Picture of Tresiba

Figure 12. Product Picture of Toujeo

Figure 13. Product Picture of Basaglar

Figure 14. Product Picture of Biosimilar Glargines

Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2021

Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2022)

Figure 17. Basal Insulin (Long-Acting Insulin) Consumed in Type 1 Diabetes

Figure 18. Global Basal Insulin (Long-Acting Insulin) Market: Type 1 Diabetes (2017-2022) & (K Units)

Figure 19. Basal Insulin (Long-Acting Insulin) Consumed in Type 2 Diabetes

Figure 20. Global Basal Insulin (Long-Acting Insulin) Market: Type 2 Diabetes (2017-2022) & (K Units)

Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application in 2021

Figure 23. Basal Insulin (Long-Acting Insulin) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company in 2021

Figure 25. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)

Figure 28. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Basal Insulin (Long-Acting Insulin) Sales 2017-2022 (K Units)

Figure 30. Americas Basal Insulin (Long-Acting Insulin) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Basal Insulin (Long-Acting Insulin) Sales 2017-2022 (K Units)

Figure 32. APAC Basal Insulin (Long-Acting Insulin) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Basal Insulin (Long-Acting Insulin) Sales 2017-2022 (K Units)

Figure 34. Europe Basal Insulin (Long-Acting Insulin) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2021

Figure 38. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2021

Figure 39. United States Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2021

Figure 44. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Regions in 2021

Figure 45. China Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2021

Figure 52. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2021

Figure 53. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2021

Figure 60. Egypt Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Basal Insulin (Long-Acting Insulin) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin) in 2021

Figure 66. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)

Figure 67. Industry Chain Structure of Basal Insulin (Long-Acting Insulin)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles